Morgan Stanley’s Vascular Solutions Inc VASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-86,440
| Closed | -$4.85M | – | 6729 |
|
|
2016
Q4 | $4.85M | Buy |
86,440
+75,727
| +707% | +$3.86M | ﹤0.01% | 3026 |
|
|
2016
Q3 | $517K | Buy |
10,713
+4,432
| +71% | +$206K | ﹤0.01% | 4504 |
|
|
2016
Q2 | $261K | Buy |
6,281
+451
| +8% | +$16.8K | ﹤0.01% | 4802 |
|
|
2016
Q1 | $190K | Sell |
5,830
-25,649
| -81% | -$739K | ﹤0.01% | 5009 |
|
|
2015
Q4 | $1.08M | Sell |
31,479
-12,816
| -29% | -$434K | ﹤0.01% | 3992 |
|
|
2015
Q3 | $1.44M | Buy |
44,295
+26,070
| +143% | +$934K | ﹤0.01% | 3808 |
|
|
2015
Q2 | $633K | Sell |
18,225
-3,685
| -17% | -$120K | ﹤0.01% | 4532 |
|
|
2015
Q1 | $663K | Sell |
21,910
-10,860
| -33% | -$312K | ﹤0.01% | 4453 |
|
|
2014
Q4 | $890K | Buy |
32,770
+13,244
| +68% | +$360K | ﹤0.01% | 4240 |
|
|
2014
Q3 | $482K | Sell |
19,526
-14,265
| -42% | -$338K | ﹤0.01% | 4601 |
|
|
2014
Q2 | $749K | Buy |
33,791
+4,473
| +15% | +$97.9K | ﹤0.01% | 4284 |
|
|
2014
Q1 | $767K | Buy |
29,318
+19,534
| +200% | +$486K | ﹤0.01% | 4225 |
|
|
2013
Q4 | $226K | Sell |
9,784
-24,362
| -71% | -$477K | ﹤0.01% | 4968 |
|
|
2013
Q3 | $573K | Sell |
34,146
-10,247
| -23% | -$166K | ﹤0.01% | 4236 |
|
|
2013
Q2 | $654K | Buy |
+44,393
| New | +$698K | ﹤0.01% | 4063 |
|
Other funds holding VASC
Morgan Stanley's VASC Position: Q1 2017 in Review
Morgan Stanley sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 86,440 shares — an estimated $4.85M sold.
Morgan Stanley first reported a position in VASC in Q2 2013 and held it in 15 quarters. The position peaked at $4.85M in Q4 2016. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.
- Morgan Stanley reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
- Morgan Stanley sold 86,440 Vascular Solutions Inc shares in Q1 2017, an estimated $4.85M.
- Morgan Stanley first reported a position in Vascular Solutions Inc in Q2 2013 and held it in 15 quarters.
- Morgan Stanley's Vascular Solutions Inc position peaked at $4.85M in Q4 2016.
- 1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.
Based on Morgan Stanley's 13F filing for Q1 2017, filed 12 May 2017.